Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

During the Trading Day
272.88 -5.70 / -2.05%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
270.50 -2.38 / -0.87%
Volume: 43.4K
Health Technology
Pharmaceuticals: Generic

Company Description

Allergan Plc operates as an investment holding company. It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products. The company operates through the following segments: North American Brands, North American Generics and International, and Anda. The company was founded on October 1, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Allergan Plc
1 Grand Canal Square
Dublin Dublin 2
Investor Relations:
(862) 261-7152



Mutual fund holders45.04%
Other institutional44.10%
Individual stakeholders0.12%

Top Executives

Brenton L. SaundersPresident, Chief Executive Officer & Director
Robert A. StewartChief Operating Officer
Maria Teresa HiladoChief Financial Officer
Jonathon KellermanGlobal Chief Compliance Officer & Executive VP
Karen L. LingChief Human Resources Officer & Executive VP